April 11, 2023
MSD launched its 15-valent pneumococcal conjugate vaccine Vaxneuvance Aqueous Suspension Syringes in Japan on April 10, the company said the same day. The vaccine was approved in September last year for the prevention of pneumococcal infections in the elderly, or...read more